CD4 and myeloid sarcoma: Following successful autologous hematopoietic stem cell transplantation, miR-155, miR-16 and miR-142 see sustained downregulation in CD4+ and CD8+ T cells of MS patients, along with an increase in the number of Treg cells that are associated with myelin repair [53].